Skip to main navigation Skip to search Skip to main content

Findings on Solid Cancer Reported by Investigators at Seoul National University (Avelumab In Paediatric Patients With Refractory or Relapsed Solid Tumours: Dose-escalation Results From an Open-label, Single-arm, Phase 1/2 Trial)

Press/Media

Period26 Oct 2023

Media coverage

1

Media coverage

  • TitleFindings on Solid Cancer Reported by Investigators at Seoul National University (Avelumab In Paediatric Patients With Refractory or Relapsed Solid Tumours: Dose-escalation Results From an Open-label, Single-arm, Phase 1/2 Trial)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date26/10/23
    PersonsWon Gu Lee